Pre-launch · Investor Overview

Building the category leader in
global midlife women's care.

Over 1 billion women will experience menopause by 2025. 70% say they feel dismissed by their GP. The federal government just committed $793Mto women's health — and the demand for real care has never been greater.

HerMidlife is building the integrated platform this moment requires — starting with the open, sourced reference layer that is already live.

The Problem

The world's largest
underserved health market.

Midlife women's health has been systematically overlooked by the healthcare system, by employers, and by technology. The data is staggering — and so is the opportunity.

70%
feel dismissed

Women who say their GP dismissed or minimised perimenopause symptoms

80%
unmet need

Women who want personalised midlife care but don't currently receive it

1 in 2
impacted at work

Women who say perimenopause symptoms affect their job performance

$150B
workforce loss

Estimated annual global workforce productivity lost to unmanaged menopause symptoms

Newson Health Research, 2023

The Market

A massive, tailwind-driven
category ready to be defined.

3.4M
TAM — Global Menopause Market

Women entering menopause annually worldwide — a rapidly growing health market

WHO, 2025

1B+
Women in transition

Women globally who will experience menopause by 2025, per WHO estimates

World Health Organization, 2025

$17.3B
Global Menopause Market

Projected to reach $27.4B by 2030 at 6.9% CAGR

Grand View Research, 2024

$1.2B
FemTech VC Funding

Global venture capital into women's health in 2024

PitchBook / FemTech Analytics

TAM

3.4M women

Women globally experiencing perimenopause and menopause symptoms — an enormous, largely unserved market.

SAM

~1.5M women

Women actively seeking care, education, or telehealth solutions today. At an average annual wallet of ~$1,000 per woman, this is a ~$1.5B serviceable market.

SOM

0.5% = ~$7.5M ARR

Capturing just half a percent of SAM within 3 years is a realistic beachhead. Bull case: 2% capture = ~$30M ARR by Year 3.

Why Now

The biggest tailwind
in global women's health.

For the first time, global policy, capital, and public awareness are aligning around midlife women's health. This is a once-in-a-decade market window.

$1.2B
FemTech VC Funding

Global venture capital invested in FemTech and women's health platforms in 2024 alone

PitchBook / Rock Health, 2024

7.4 yrs
Median Symptom Duration

Median duration of vasomotor symptoms — a multi-year care relationship, not a single transaction

SWAN cohort, JAMA Internal Medicine 2015

0
GP Training Programs

Menopause training is mandatory in medical school curricula globally — a gap driving demand for specialist platforms

Menopause Society, 2024

10+
Countries with policies

Countries have now introduced workplace menopause policies or legislation — the regulatory tailwind is building

Global Workforce Policy Review, 2025

The Solution

The world's most compassionate,
integrated midlife platform.

We combine what today lives in five separate places — your GP, your psychologist, your pharmacy, your wellness apps, and your friend group — into a single, continuous, doctor-led experience.

Doctor-led care

Every consultation is led by a clinician trained in perimenopause, HRT, and midlife health — not triaged by algorithms.

Integrated platform

Clinical care, emotional support, education, community, and continuous follow-up — in one place, not scattered across apps.

AI-powered continuity

Symptom tracking, personalised insights, and longitudinal care — designed to support women for years, not just a single visit.

B2B workplace layer

Corporate wellness programs that help employers retain midlife women — addressing the $17B annual workforce loss head-on.

Where We Are

Pre-launch.
Content live. Care layer next.

We're building in the open and going to market with a free community events and digital outreach — the moment the world sees HerMidlife for the first time.

Next

Q2 2026

Platform launch

HerMidlife goes live. Doctor-led education on perimenopause, mood, sleep, and hormonal health. The public launch of the HerMidlife platform.

Planned

Q2–Q3 2026

Telehealth consultations go live

Book-a-doctor functionality launches globally. Evidence-backed assessments and personalised care plans for women everywhere.

Planned

Q3 2026

Corporate pilot programs

First enterprise wellness partnerships — workplace education, symptom screening, and care navigation for midlife employees.

Planned

Q4 2026

Continuous care & community

Symptom tracking, patient community, follow-up care loops, and AI-assisted insights. Beginning the transition from single visits to longitudinal midlife care.

The Team

Doctor-led. Builder-led.
Globally-minded.

A founder with deep technology expertise and a conviction about women's health — united by the belief that every woman deserves to be heard.

Meet the Founder

The Ask

Partner with us to define a category.

We're meeting mission-aligned investors as we move from reference layer to care delivery. If you believe women everywhere deserve better — let's talk.

Her Midlife · Empower · Educate · Transform